TY  - RPRT
TI  - SRPK1 is a determinant of chemoresistance to Docetaxel in prostate cancer
AU  - Duzgun, D.
AU  - Read, W.
AU  - Oltean, S.
PY  - 2026
DO  - 10.64898/2026.09.16.751805
UR  - https://www.biorxiv.org/content/10.64898/2026.09.16.751805v1
ID  - 10.64898/2026.09.16.751805
ER  -